The Deeming Rule subjects electronic cigarettes and other vaping products to more onerous restrictions than combustible cigarettes under the Tobacco Control Act. Nicopure Labs asserts that the FDA's rulemaking process violated the Administrative Procedure Act, and that the Deeming Rule violates the First Amendment to the United States Constitution.
"We strongly believe that this rule violates the Constitution and the process by which it was put into effect is fundamentally flawed and not legally grounded," said Jeff Stamler, CEO and co-founder of Nicopure Labs. "Further, we object to the vaping industry being subjected to greater restrictions than traditional tobacco companies, with which Nicopure Labs has no affiliation. We trust that the U.S. District Court will see the merit of our arguments."
About Nicopure Labs, LLC
Operating since 2009, Tampa-based Nicopure Labs, LLC is an industry leading e-liquid manufacturer with operations in the U.S. and Europe. Nicopure Labs has recently upgraded its 110,000 sq. ft. manufacturing and distribution operations in Gainesville, Florida to include a 10,000 sq. ft. ISO 7 Clean Room. Distributing to over 90 countries worldwide, Nicopure Labs has also expanded its presence with the recent addition of a European headquarters in the Netherlands and offices in England.
For more information about Nicopure Labs, distribution or reseller information, please visit nicopure.com. For additional information regarding their premium American-made e-liquids and innovative line of vaporizer devices, please visit halocigs.com.
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nicopure-labs-files-motion-for-summary-judgment-against-fda-over-deeming-rule-300297023.html
SOURCE Nicopure Labs